ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

HASSAN ABOULEISH MD

22 HARTFORD ST SIGRID E TOMPKINS HEALTH CENTER

Houlton | Maine | 04730

(207) 532-4068

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,067Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 247

$1.92M Total Retail Price of All Prescriptions

Rank: 1 out of 247

973 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 973 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 973 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 20,818 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
OMEPRAZOLE 994 872 1 4
LEVOTHYROXINE SODIUM 992 922 2 3
FUROSEMIDE 941 872 3 5
METOPROLOL TARTRATE 729 677 4 7
PREDNISONE 695 629 5 21
GABAPENTIN 591 485 6 17
ATORVASTATIN CALCIUM 538 425 7 8
LISINOPRIL 526 427 8 2
PANTOPRAZOLE SODIUM 506 410 9 19
METFORMIN HCL 474 339 10 12
AMLODIPINE BESYLATE 441 382 11 6
SIMVASTATIN 434 410 12 1
WARFARIN SODIUM 413 383 13 13
HYDROCODONE-ACETAMINOPHEN 343 237 S3 14 11
SPIRONOLACTONE 342 314 15 53
SERTRALINE HCL 331 274 16 16
SPIRIVA 318 281 17 26
JANUVIA 300 259 18 56
NEXIUM 297 255 19 42
ADVAIR DISKUS 269 213 20 18
METOPROLOL SUCCINATE 245 209 21 14
DIOVAN 245 208 21 38
CYMBALTA 242 138 23 52
CRESTOR 240 201 24 30
KLOR-CON M20 237 231 25 44
CARVEDILOL 236 214 26 59
ALLOPURINOL 232 192 27 33
AZITHROMYCIN 231 170 28 48
CITALOPRAM HBR 226 202 29 20
GLIMEPIRIDE 216 181 30 80
PRAVASTATIN SODIUM 212 192 31 23
TAMSULOSIN HCL 199 144 32 31
DONEPEZIL HCL 197 187 33 35
PRADAXA 190 177 34 96
POTASSIUM CHLORIDE 170 151 35 36
NAPROXEN 168 136 36 113
SYMBICORT 167 142 37 92
LISINOPRIL-HYDROCHLOROTHIAZIDE 166 129 38 51
DILTIAZEM 24HR CD 158 156 39 120
MIRTAZAPINE 157 155 40 46
ISOSORBIDE MONONITRATE ER 156 137 41 40
QUETIAPINE FUMARATE 156 156 41 84
MELOXICAM 152 108 43 70
CELEBREX 151 145 44 110
DEXILANT 148 93 45 119
DIOVAN HCT 147 120 46 96
CLOPIDOGREL 141 107 47 70
AMITRIPTYLINE HCL 141 84 R 47 55
ATENOLOL 141 140 47 10
JANUMET 141 126 47 158
CIPROFLOXACIN HCL 138 126 51 89
NAMENDA 133 133 52 47
LIPITOR 132 106 53 50
OXYCODONE HCL 129 81 S2 54 27
TRAMADOL HCL 127 107 55 25
SINGULAIR 122 77 56 109
PROAIR HFA 120 94 57 29
FLUTICASONE PROPIONATE 120 105 57 37
LOVASTATIN 115 99 59 22
ROPINIROLE HCL 114 81 60 69
VENLAFAXINE HCL ER 113 63 61 64
PLAVIX 112 91 62 106
PEN NEEDLE 112 62 62 79
COMBIVENT 112 105 62 63
LANTUS 106 69 65 39
TRAZODONE HCL 106 93 65 28
RISPERIDONE 104 67 67 58
ZETIA 103 102 68 62
NOVOLOG 99 81 69 99
FENTANYL 95 74 S2 70 72
POLYETHYLENE GLYCOL 3350 94 68 71 77
HYDROCHLOROTHIAZIDE 94 82 71 9
TEKTURNA 92 82 73 178
CLOTRIMAZOLE-BETAMETHASONE 86 72 74 181
EXELON 85 85 75 102
INSULIN SYRINGE 85 53 75 68
TRIAMCINOLONE ACETONIDE 84 68 77 94
NITROGLYCERIN PATCH 82 79 78 137
PHENYTOIN SODIUM EXTENDED 81 62 79 184
VYTORIN 79 55 80 155
DILTIAZEM ER 78 58 81 108
PAROXETINE HCL 78 52 81 45
ZOLPIDEM TARTRATE 76 44 83 24
ESCITALOPRAM OXALATE 74 62 84 65
KLOR-CON M10 72 60 85 95
AMIODARONE HCL 71 70 86 198
GLIPIZIDE 71 52 86 43
CLOBETASOL PROPIONATE 70 57 88 142
MONTELUKAST SODIUM 67 47 89 205
VESICARE 67 63 89 143
CYCLOBENZAPRINE HCL 65 26 R 91 54
OLANZAPINE 62 61 92 106
AMLODIPINE BESYLATE-BENAZEPRIL 62 47 92 157
PRAMIPEXOLE DIHYDROCHLORIDE 61 55 94 123
ENABLEX 60 58 95 160
LYRICA 60 41 95 118
ULORIC 60 51 95 213
CEPHALEXIN 60 56 95 169
RANITIDINE HCL 59 44 99 34
LOSARTAN POTASSIUM 58 58 100 15
SEROQUEL 57 57 101 216
GLYBURIDE 57 53 R 101 41
OXYCODONE-ACETAMINOPHEN 56 29 S2 103 87
OXYCONTIN 56 14 S2 103 124
METOCLOPRAMIDE HCL 55 43 105 161
ACTONEL 55 55 105 217
NYSTATIN 54 47 107 129
SEROQUEL XR 54 38 107 219
DIGOXIN 52 40 109 83
VERAPAMIL ER 52 40 109 135
DILTIAZEM 24HR ER 51 51 111 171
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.